Analystreport

Lexicon Pharmaceuticals (NASDAQ: LXRX) had its price target raised by analysts at Wedbush from $38.00 to $40.00. They now have an "outperform" rating on the stock.

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors